[1]
|
Lippi, G., Sanchis-Gomar, F. and Cervellin, G. (2020) Global Epidemiology of Atrial Fibrillation: An Increasing Epidemic and Public Health Challenge. International Journal of Stroke, 16, 217-221. https://doi.org/10.1177/1747493019897870
|
[2]
|
Ding, Y., Wang, Y., Zhang, W., et al. (2024) Roles of Biomarkers in Myocardial Fibrosis. Aging and Disease, 11, 1157-1174. https://doi.org/10.14336/AD.2020.0604
|
[3]
|
Benjamin, E.J., et al. (2017) Atrial Fibrillation Epidemiology, Pathophysiology, and Clinical Outcomes. Circulation Research: A Journal of the American Heart Association, 120, 1501-1517.
|
[4]
|
Chen, B. and Frangogiannis, N.G. (2021) Chemokines in Myocardial Infarction. Journal of Cardiovascular Translational Research, 14, 35-52. https://doi.org/10.1007/s12265-020-10006-7
|
[5]
|
Bernstein, K.E. (2004) Mice with Cardiac-Restricted Angiotensin-Converting Enzyme (ACE) Have Atrial Enlargement, Cardiac Arrhythmia, and Sudden Death. American Journal of Pathology, 165, 1019-1032. https://doi.org/10.1016/S0002-9440(10)63363-9
|
[6]
|
Frustaci, A., Chimenti, C., Bellocci, F., et al. (1997) Histological Substrate of Atrial Biopsies in Patients with Lone Atrial Fibrillation. Circulation, 96, 1180-1184. https://doi.org/10.1161/01.CIR.96.4.1180
|
[7]
|
Burstein, B. and Nattel, S. (2008) Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial Fibrillation. Journal of the American College of Cardiology, 51, 802-809. https://doi.org/10.1016/j.jacc.2007.09.064
|
[8]
|
Yao, C., Veleva, T., Scott, L., et al. (2018) Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation. Circulation, 138, 2227-2242.
|
[9]
|
Li, G.L., Yang, J., Zhang, D.M., et al. (2022) Research Progress of Myocardial Fibrosis and Atrial Fibrillation. Frontiers in Cardiovascular Medicine, 9, Article ID: 889706.
|
[10]
|
Kallergis, E.M., Manios, E.G., Kanoupakis, E.M., et al. (2008) Extracellular Matrix Alterations in Patients with Paroxysmal and Persistent Atrial Fibrillation: Biochemical Assessment of Collagen Type-I Turnover. Journal of the American College of Cardiology, 52, 211-215. https://doi.org/10.1016/j.jacc.2008.03.045
|
[11]
|
Chang, Y.L., Jing, R.Z., Wan, N.H., et al. (2021) Atrial Fibrosis Underlying Atrial Fibrillation (Review). International Journal of Molecular Medicine, 47, Article No. 9. https://doi.org/10.3892/ijmm.2020.4842
|
[12]
|
Karam, B.S., Chavez-Moreno, A., Koh, W., et al. (2017) Oxidative Stress and Inflammation as Central Mediators of Atrial Fibrillation in Obesity and Diabetes. Cardiovascular Diabetology, 16, Article No. 120. https://doi.org/10.1186/s12933-017-0604-9
|
[13]
|
Branimir, P., Janko, S., Aleksandar, B., et al. (2023) The N-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation. Biomolecules, 13, Article No. 605. https://doi.org/10.3390/biom13040605
|
[14]
|
Pascual-Figal, D.A. and Januzzi, J.L. (2015) The Biology of ST2: The International ST2 Consensus Panel. American Journal of Cardiology, 115, 3B-7B. https://doi.org/10.1016/j.amjcard.2015.01.034
|
[15]
|
Liu, Y., Niu, X.H., Yin, X., et al. (2018) Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation. Journal of the American Heart Association, 7, e008083. https://doi.org/10.1161/JAHA.117.008083
|
[16]
|
Aimo, A., Vergaro, G., Passino, C., et al. (2016) Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis. JACC: Heart Failure, 5, 280-286. https://doi.org/10.1016/j.jchf.2016.09.010
|
[17]
|
Tan, R., Yu, H., Han, X., et al. (2021) Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence after Radiofrequency Ablation of Persistent Atrial Fibrillation. Frontiers in Cardiovascular Medicine, 8, Article ID: 653312.
|
[18]
|
Gökhan, A., Ahmet, Y., Can, O.Y., et al. (2022) The Predictive Value of Galectin-3 Levels on Left Atrial Low Voltage Areas Assessed by High-Density Mapping in Patients with Paroxysmal Atrial Fibrillation. Journal of Arrhythmia, 38, 353-362. https://doi.org/10.1002/joa3.12703
|
[19]
|
Hernández-Romero, D., Vílchez, J.A., Lahoz, Á., et al. (2017) Galectin-3 as a Marker of Interstitial Atrial Remodelling Involved in Atrial Fibrillation. Scientific Reports, 7, Article No. 40378. https://doi.org/10.1038/srep40378
|
[20]
|
Ruan, Z.-B., Gao, R.-F., Wang, F., et al. (2022) Circulating Galectin-3 and Aldosterone for Predicting Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation. Cardiovascular Therapeutics, 2022, Article ID: 6993904. https://doi.org/10.1155/2022/6993904
|
[21]
|
Zhang, Y., Zhang, S., Li, B.L., et al. (2022) Gut Microbiota Dysbiosis Promotes Age-Related Atrial Fibrillation by Lipopolysaccharide and Glucose-Induced Activation of NLRP3-Inflammasome. Cardiovascular Research, 118, 785-797. https://doi.org/10.1093/cvr/cvab114
|
[22]
|
Wang, M., Xiong, H., Lu, L., et al. (2022) Serum Lipopolysaccharide Is Associated with the Recurrence of Atrial Fibrillation after Radiofrequency Ablation by Increasing Systemic Inflammation and Atrial Fibrosis. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 2405972. https://doi.org/10.1155/2022/2405972
|
[23]
|
Wang, Z., Liang, C., Gao, Y.F., et al. (2022) Predictive Value of CTRP3 for the Disease Recurrence of Atrial Fibrillation Patients after Radiofrequency Ablation. American Journal of Translational Research, 14, 1892-1900.
|
[24]
|
Nicolás, J.L., Marinela, C., Teba, G., et al. (2022) The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation. International Journal of Molecular Sciences, 23, Article No. 11107. https://doi.org/10.3390/ijms231911107
|
[25]
|
Takenori, I., Yoshihisa, N., Yutaro, K., et al. (2022) Pre-Procedural Predictors of Left Atrial Low-Voltage Zones in Patients Undergoing Catheter Ablation of Atrial Fibrillation. PLOS ONE, 17, e0266939. https://doi.org/10.1371/journal.pone.0266939
|
[26]
|
Mitran, E.R., Fotea, P.M.N., Iorgulescu, C., et al. (2023) Left Atrial Low-Voltage Areas Predict the Risk of Atrial Fibrillation Recurrence after Radiofrequency Ablation. Biomedicines, 11, Article No. 3261, https://doi.org/10.3390/biomedicines11123261
|
[27]
|
Antonio, B., David, T., Lluis, M., et al. (2007) Pre-Procedural Predictors of Atrial Fibrillation Recurrence after Circumferential Pulmonary Vein Ablation. European Heart Journal, 28, 836-841. https://doi.org/10.1093/eurheartj/ehm027
|
[28]
|
Laura, U., Andreas, B., Benjamin, M.S., et al. (2013) Genetic ACE I/D Polymorphism and Recurrence of Atrial Fibrillation after Catheter Ablation. Circulation. Arrhythmia and Electrophysiology, 6, 732-737. https://doi.org/10.1161/CIRCEP.113.000253
|
[29]
|
Luisa, C., Vanesa, B., Manuel, M., et al. (2020) Association between Interatrial Block, Left Atrial Fibrosis, and Mechanical Dyssynchrony: Electrocardiography-Magnetic Resonance Imaging Correlation. Journal of Cardiovascular Electrophysiology, 31, 1719-1725. https://doi.org/10.1111/jce.14608
|
[30]
|
Miao, Y.X., Xu, M., Yang, L., et al. (2021) Investigating the Association between P Wave Duration and Atrial Fibrillation Recurrence after Radiofrequency Ablation in Early Persistent Atrial Fibrillation Patients. International Journal of Cardiology, 351, 48-54.
|
[31]
|
Antonio, C., Sandrine, V., Konstantinos, T., et al. (2023) Amplified Sinus-P-Wave Analysis Predicts Outcomes of Cryoballoon Ablation in Patients with Persistent and Long-Standing Persistent Atrial Fibrillation: A Multicentre Study. Frontiers in Cardiovascular Medicine, 10, Article ID: 1110165.
|
[32]
|
Daniel, M., Rady, H., Ryna, T., et al. (2020) Real-World Experience with Implantable Loop Recorder Monitoring to Detect Subclinical Atrial Fibrillation in Patients with Cryptogenic Stroke: The Value of P Wave Dispersion in Predicting Arrhythmia Occurrence. International Journal of Cardiology, 327, 86-92. https://doi.org/10.1016/j.ijcard.2020.11.019
|